bumetanide and fg 9041
bumetanide has been researched along with fg 9041 in 2 studies
Research
Studies (2)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
| Arisi, I; Brandi, R; Capsoni, S; Cattaneo, A; Cherubini, E; D'Onofrio, M; Franzot, J; Lagostena, L; Rosato-Siri, M | 1 |
Other Studies
2 other study(ies) available for bumetanide and fg 9041
| Article | Year |
|---|---|
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
In the adult hippocampus, chronic nerve growth factor deprivation shifts GABAergic signaling from the hyperpolarizing to the depolarizing direction.
Topics: 2-Amino-5-phosphonovalerate; alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Antibodies, Neutralizing; Biophysics; Bumetanide; Electric Stimulation; Excitatory Amino Acid Agonists; Excitatory Amino Acid Antagonists; Excitatory Postsynaptic Potentials; GABA Agonists; GABA Antagonists; gamma-Aminobutyric Acid; Gene Expression Regulation; Hippocampus; In Vitro Techniques; Ion Channel Gating; Isonicotinic Acids; K Cl- Cotransporters; Mice; Mice, Transgenic; Nerve Growth Factor; Neurons; Patch-Clamp Techniques; Pyridazines; Quinoxalines; Receptors, Nicotinic; RNA, Messenger; Sodium Potassium Chloride Symporter Inhibitors; Symporters | 2010 |